Drug Combination Details
General Information of the Combination (ID: C97955) | |||||
---|---|---|---|---|---|
Name | Arsenic trioxide NP Info | + | Thalidomide Drug Info | ||
Structure | + | ||||
Disease |
Multiple myeloma
[ICD-11: 2A83]
|
Phase 2 | [1] | ||
Acute myeloid leukemia
[ICD-11: 2A60]
|
Investigative | [2] | |||
Acute lymphoblastic leukemia
[ICD-11: 2B33]
|
Investigative | [3] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [3] | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | AKT1 | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | BECN1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | IL6 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | MAP1LC3A | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | MEK1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | mTOR | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | PIK3CB | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | PTEN | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | SQSTM1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | ULK1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | VEGFC | Molecule Info |
Pathway MAP
|
||
In-vitro Model | KG-1 | CVCL_0374 | Adult acute myeloid leukemia | Homo sapiens | ||
U-937 | CVCL_0007 | Adult acute monocytic leukemia | Homo sapiens | |||
Experimental
Result(s) |
Arsenic trioxide and thalidomide combination induces autophagy along with apoptosis in acute myeloid cell lines. | |||||
Experiment 2 Reporting the Effect of This Combination | [2] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | VEGFA | Molecule Info |
Pathway MAP
|
|
In-vitro Model | U-937 | CVCL_0007 | Adult acute monocytic leukemia | Homo sapiens | ||
KG-1 | CVCL_0374 | Adult acute myeloid leukemia | Homo sapiens | |||
Experimental
Result(s) |
Arsenic trioxide and thalidomide combination showed inhibitory effects of on angiogenesis and vascular endothelial growth factor expression in leukemia cells. |